Aviance Capital Partners, LLC Amgen Inc Transaction History

Aviance Capital Partners, LLC

$733 Million
Q3 2024

A detailed history of Aviance Capital Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 31,834 shares of AMGN stock, worth $8.41 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

31,834

Previous 31,789 0.14%

Holding current value

$8.41 Million

Previous $9.93 Million 3.27%

% of portfolio

1.4%

Previous 1.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $13,922 - $15,182	45 Added 0.14%	31,834 $10.3 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $76,985 - $93,557	293 Added 0.93%	31,789 $9.93 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $2.13 Million - $2.57 Million	7,910 Added 33.54%	31,496 $8.95 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $134,498 - $151,729	-526 Reduced 2.18%	23,586 $6.79 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $25,800 - $32,032	118 Added 0.49%	24,112 $6.48 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $308,763 - $365,106	1,441 Added 6.39%	23,994 $5.33 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $29,578 - $36,051	-131 Reduced 0.58%	22,553 $5.45 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $23,361 - $29,683	-102 Reduced 0.45%	22,684 $5.96 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $180,690 - $203,785	-805 Reduced 3.41%	22,786 $5.14 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $67,598 - $75,224	293 Added 1.26%	23,591 $5.74 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $2,631 - $2,910	12 Added 0.05%	23,298 $5.63 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $79,552 - $91,040	400 Added 1.75%	23,286 $5.24 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $246,657 - $288,989	1,162 Added 5.35%	22,886 $4.87 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $139,680 - $154,965	598 Added 2.83%	21,724 $5.3 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $131,814 - $153,608	-594 Reduced 2.73%	21,126 $5.26 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $20,772 - $24,736	96 Added 0.44%	21,720 $4.99 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $99,960 - $111,164	426 Added 2.01%	21,624 $5.5 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $187,721 - $230,360	949 Added 4.69%	21,198 $5 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $35,901 - $47,614	-197 Reduced 0.96%	20,249 $4.11 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $168,207 - $216,204	-889 Reduced 4.17%	20,446 $4.93 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $58,152 - $69,679	334 Added 1.59%	21,335 $4.13 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $83,350 - $97,705	500 Added 2.44%	21,001 $3.87 Million
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $1.08 Million - $1.22 Million	-5,993 Reduced 22.62%	20,501 $3.9 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $656,155 - $765,943	-3,678 Reduced 12.19%	26,494 $5.16 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $263,482 - $297,041	1,422 Added 4.95%	30,172 $6.25 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $83,357 - $93,628	502 Added 1.78%	28,750 $5.31 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $569,454 - $665,478	-3,361 Reduced 10.63%	28,248 $4.82 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $95,872 - $107,119	568 Added 1.83%	31,609 $5.5 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $5.19 Million - $5.93 Million	31,041	31,041 $5.79 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.

Account

Aviance Capital Partners, LLC Amgen Inc Transaction History